You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype

Article metrics

Article menu

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype

 

Online download statistics by month:

Online download statistics by month: March 2022 to December 2025

AbstractFullPdf
Mar 2022486498290
Apr 2022184187101
May 2022338351133
Jun 202221021668
Jul 202217317963
Aug 202216316452
Sep 202221522060
Oct 202224024583
Nov 202216416474
Dec 202215615670
Jan 202313413562
Feb 202316116179
Mar 2023171178108
Apr 202312512573
May 2023869160
Jun 2023929249
Jul 202310510576
Aug 2023115114100
Sep 2023979940
Oct 202313313370
Nov 202313413599
Dec 2023176179139
Jan 2024187188123
Feb 202413713789
Mar 2024161161169
Apr 2024128132108
May 2024166168102
Jun 202413213483
Jul 2024158159147
Aug 202410310091
Sep 2024818464
Oct 2024148161114
Nov 2024158162132
Dec 202427527794
Jan 202512212372
Feb 2025224230170
Mar 2025172172122
Apr 2025206207106
May 2025143145103
Jun 20259710090
Jul 2025220
Aug 2025110
Oct 2025550
Dec 2025001
Total666467753929